mibefradil has been researched along with Diabetic Neuropathies in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hong, SJ; Hwang, SM; Jevtovic-Todorovic, V; Obradovic, ALj; Scarpa, J; Todorovic, SM | 1 |
1 other study(ies) available for mibefradil and Diabetic Neuropathies
| Article | Year |
|---|---|
CaV3.2 T-type calcium channels in peripheral sensory neurons are important for mibefradil-induced reversal of hyperalgesia and allodynia in rats with painful diabetic neuropathy.
Topics: Animals; Calcium Channel Blockers; Calcium Channels, T-Type; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Female; Hyperalgesia; Mibefradil; Rats; Rats, Sprague-Dawley; Sensory Receptor Cells; Streptozocin | 2014 |